Introduction: Fungal infections in the immunocompromised host are fairly common. Of the mycoses, Fusarium species are an emerging threat. Fusarium infections have been reported in solid organ transplants, with three reports of the infection in patients who had received renal transplants. To the best of our knowledge, this is the first case of an isolated cutaneous lesion as the only form of infection. Case presentation: We report the case of a 45-year-old South Indian man who presented with localized cutaneous Fusarium infection following a renal transplant.
Introduction
Fusarium species are common soil saprophytes and plant pathogens. Young and Meyers [1] first reported Fusarium infection in the late 1970s. Since then, several species have been recognized to be agents of superficial infections (keratitis, cutaneous infections, onychomycosis and infection of wounds or burns) in humans [2] . More recently, deep-seated, disseminated infections have been increasingly described in immunocompromised patients, especially in neutropenic patients [3, 4] . The prognosis is very poor, and death occurs in up to 70% of the cases despite antifungal therapy [4] . The Fusarium species most frequently involved in human infections are Fusarium solani, F. oxysporum and F. moniliforme.
Case report
A 45-year-old South Indian man underwent a renal allograft transplant for end-stage renal disease. He was administered tacrolimus, mycophenolate and prednisolone as immunosuppressive therapy. On follow-up at six months, he complained of a small, painless nodule on his right calf. He had no fever, redness or pruritus. He had no other opportunistic infection. Clinical examination revealed a subcutaneous, 2 × 2-cm, firm, violaceous nodule with normal surrounding skin ( Figure 1 ). He had no other similar lesions. There was no regional lymphadenopathy. The rest of the physical examination was normal. His hemogram was normal, as were his computed tomographic chest and abdominal ultrasound scans. He underwent fine-needle aspiration of the nodule, which was reported to have inflammatory cells and a few fungal hyphae. He subsequently underwent excision of the nodule, which was sent for microbiological evaluation. The finding was reported to be Fusarium solani.
A biopsy sample was cultured for fungi on Sabouraud dextrose agar without cycloheximide and was incubated at 25°C in air for four days. It grew whitish-gray cottony colonies suggestive of Fusarium spp. Successive subcultures performed on potato dextrose agar in the dark stained with periodic acid-Schiff showed sickle-shaped, multiseptated macroconidia, and one-to two-celled microconidia had formed from unbranched phialides, conidiophores and chlamydospores typical of Fusarium solani (Figure 2) . Subsequently, species identification was further performed using immunohistochemistry (Figure 3) . The patient was successfully treated with surgical excision of the lesion followed by four weeks of oral voriconazole treatment.
Discussion
Fusarium species are ubiquitous and may be found in the soil and air and on plants. In humans, Fusarium species cause disease that is localized, focally invasive or disseminated. The pathogen generally affects immunocompromised individuals, with infection of immunocompetent persons being rarely reported. Localized infection includes septic arthritis, endophthalmitis, osteomyelitis, cystitis and brain abscess. In these situations, a relatively good response may be expected following appropriate surgery and oral antifungal therapy. Disseminated infection occurs when two or more noncontiguous sites are involved [5] . The skin can be an important and early clue to diagnosis, since cutaneous lesions may be observed at an early stage of the disease. Typical skin lesions may be painful red or violaceous nodules, the center of which often becomes ulcerated and covered by a black eschar. The multiple necrotizing lesions are often observed on the trunk and the extremities [6] .
Our patient had a single, localized nodule that was treated successfully with surgical excision and antifungal therapy. He did not have any signs of disseminated infection. At the last follow-up appointment, he had no symptoms of any disseminated fungemia. Amphotericin has been the drug of choice to treat most fungal infections. The use of azoles, namely, voriconazole, posaconazole and ravuconazole, has also been found to be promising [7] . As the patient was a renal transplant recipient, we chose to use voriconazole to treat him as it has shown good response in most zygomycoses.
Conclusion
Opportunistic infections in transplant recipients can be life-threatening. Fusarium infections are recognized more often, and unless they are diagnosed and treated early, they can be a cause of significant morbidity and mortality. 
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